International Paper Co (IP) Stock News

Pershing Square USA, Bill Ackman's closed-end fund, is trading at a 20% discount to its net asset value (NAV) since its IPO. Unlike Berkshire Hathaway, which is an operating company, Pershing Square USA is a closed-end fund that trades on exchanges based on supply and demand. While the discount may seem attractive, investors should understand that closed-end funds often trade at discounts for extended periods, and the discount alone shouldn't be the sole reason for investment.

SpaceX's stock fell below its $135 IPO price following a Starship launch delay, but the article argues the delay itself is unlikely to materially impact the company's long-term investment thesis. The stock decline is attributed more to thin trading float (only 4% of shares trade publicly), AI sector sell-offs, and pending lock-up expirations rather than the business fundamentals. Near-term revenue drivers like Starlink and AI compute deals remain unaffected by the delay.

Foreign investors value the company at around $4.5 billion, while some domestic institutional investors estimate it between $3 billion and $3.5 billion

Cerebras Systems, which completed the year's biggest IPO by May with $5.5 billion raised, is expected by Wall Street to gain 47% over the next 12 months. The company designs giant AI chips that claim to surpass Nvidia's GPUs in speed, with 58 times larger size and 2,000 times more memory bandwidth. While revenue grew 92% to $193 million in the latest quarter, the stock carries risks including reliance on a small customer base and lack of profitability. The article recommends it for aggressive investors but cautions conservative investors to stick with established players like Nvidia.

The Temasek Holdings-backed company is planning to raise as much as ₹11,000 crore through a share sale that’s likely to be launched in the week starting July 27

Analyst recommendations on unlisted companies are uncommon in India and globally, making the call stand out ahead of listing of its shares on rival bourse

SpaceX has fallen below its $135 IPO price after an initial 20% surge. Historical analysis of major IPOs shows eight of ten experienced declines in the first three months, with an average drop of 13%. The article suggests most investors should wait for future buying opportunities rather than investing at current levels, citing the company's heavy investment needs and technology risks.

IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million plus up to €50 million in earnout consideration. The acquisition aims to create a scaled medical laser platform combining IPG's urology expertise with Lumibird Medical's ophthalmology leadership, expected to add approximately $1 billion in addressable market and be accretive to gross margin, EBITDA, and adjusted EPS. The transaction is expected to close in Q4 2026.

SpaceX stock, which opened at $150 over a month ago, is now trading below that level. Based on 26 years of historical IPO data, large IPOs typically gain only 3.5-4% in their first year, suggesting SpaceX shares could reach around $156 within 11 months. The company faces headwinds including unprofitability, massive capital expenditures ($27 billion in 2025), risky bets on Starship rocket technology, and an unproven orbital AI data center plan. Analysts' price targets range from $300-$800, but historical trends suggest more modest gains.

Unable to buy directly into ChangXin Memory Technologies Inc’s planned $9.8 billion listing because of various regulatory restrictions on participation in mainland IPOs, investors are finding backdoors

ARCpoint Inc. (TSXV: ARC), a healthcare technology company, announced it will miss its July 29, 2026 filing deadline for annual financial statements due to lack of available funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and expects to file by September 29, 2026. During the MCTO period, insiders will be restricted from trading shares, though public trading will continue.

SpaceX stock has fallen below its $135 IPO price after a dramatic reversal from its June peak, but the more significant warning comes from its debt market. The company's $25 billion bond due in 2056 has weakened to a 7.5% yield, signaling investor concerns about financing costs for the AI and infrastructure boom. Rising borrowing costs across hyperscalers could constrain capital spending efficiency and threaten the valuation assumptions underlying the AI investment thesis.

SpaceX shares fell for a fourth-straight session on Wednesday days after entering the Nasdaq-100

Ipsen conducted share buybacks between July 6-10, 2026, purchasing 28,541 shares at an average price of €166.05. The company announced that Dysport (botulinum toxin) achieved positive Phase III results in both episodic and chronic migraine trials, becoming the first botulinum toxin to meet primary endpoints in both indications.

Ipsen conducted share repurchases totaling 28,541 shares between July 6-10, 2026, at an average price of €166.05. The company announced that Dysport (botulinum toxin) achieved positive Phase III results in both episodic and chronic migraine trials, becoming the first botulinum toxin to meet primary endpoints in both indications.

For investors who missed SpaceX's IPO, established defense contractors offer steadier exposure to the space boom through government spending on Golden Dome (a space-based missile shield). Companies like Lockheed Martin, Northrop Grumman, L3Harris, RTX, and Boeing provide dividend income and diversified portfolios, though with lower growth potential than pure-play space companies.

SpaceX's stock has declined 11% since its June IPO, but the broader space sector remains strong with a $1.85 trillion market cap. Capital is returning to smaller space companies working with SpaceX on government and telecom contracts. Three alternative space stocks to consider are Rocket Lab (RKLB), AST SpaceMobile (ASTS), and Intuitive Machines (LUNR), each with different growth catalysts and profitability timelines.

SpaceX stock has declined significantly from its IPO peak of $200+ to near its $135 offering price, shedding over $800 billion in market value. The decline is attributed to concerns over the company's first-ever debt issuance and upcoming insider lockup expirations that could increase selling pressure. Despite the pullback, Wall Street remains optimistic with Morgan Stanley initiating coverage at an Overweight rating and $300 price target. The company's first quarterly earnings report in early August will be a key test for whether its operating performance can support its premium valuation.

SK Hynix's U.S. IPO debut raised $28.1 billion but experienced a 7% intraday sell-off, presenting a buying opportunity for investors. Despite short-term macroeconomic headwinds and market friction, the company benefits from a multi-year supply crunch in high-bandwidth memory (HBM) driven by AI hardware demand. SK Hynix's market share has compressed from 69% to 56-58% as Samsung and Micron ramp capacity, but advance payments from hyperscalers provide revenue visibility through 2027, decoupling earnings from traditional memory cycles.

Black Rock Coffee Bar (BRCB) faces a securities class action lawsuit alleging its IPO documents failed to disclose the adverse impact of sales cannibalization on growth metrics. The company's stock has declined over 61% from its $20 IPO price to $7.72 after revealing in Q1 2026 earnings that the sales transfer phenomenon created a 160-basis point headwind to same-store sales growth, contradicting its aggressive expansion narrative.

SpaceX, which went public on June 12 with a $2 trillion market cap, has been added to major ETFs including the Nasdaq-100. However, despite being one of the world's 10 largest companies, SpaceX's weighting in popular index funds remains minimal due to its lower free-float market cap ratio. This means the stock's volatility will have minimal impact on these ETFs, and investors in these funds need not make portfolio adjustments.

SpaceX completed the largest IPO in history at $150/share in June 2026 but has since declined, losing approximately $1 trillion in market cap from its $2.9 trillion peak. The selloff was driven by profit-taking from momentum investors and concerns about heavy capital expenditures and AI revenue scaling. However, the article argues SpaceX's vertically integrated model, recent AI partnerships with Anthropic and Google Cloud, and Starlink's low-latency network position it for long-term recovery. Investors are advised to adopt a multi-year horizon and use dollar-cost averaging rather than attempting to time a bottom.

Monster Beverage announced a 2-for-1 forward stock split effective August 10, marking its sixth split since IPO. The energy drink company has delivered exceptional returns of approximately 457,000% since going public, driven by its strategic partnership with Coca-Cola and consistent innovation. Monster has achieved 33 consecutive years of positive net sales growth and maintains the No. 2 position in the domestic energy drink market.

SpaceX stock has returned to near its IPO price after an initial surge and subsequent decline. Unlike typical 180-day lockup periods, SpaceX insiders can begin selling shares in waves starting within two months, with up to 83% of non-Musk-controlled shares potentially available for sale by Q3 earnings. The author argues this creates a 'liquidity trap' where insiders use retail investor demand as an exit opportunity.

Hagens Berman is investigating a securities class action against PicS N.V. alleging that its January 2026 IPO documents contained material misrepresentations regarding credit evaluation procedures and asset classifications. The complaint claims PicS failed to disclose that it had identified deficient credit evaluation procedures in December 2025, resulting in R$590 million in reclassifications to Stage 3 and an R$88 million ECL charge. Additionally, Stage 3 loan formation rates spiked from 3.8% in Q3 2025 to over 7% in Q4 2025, with further deterioration of 13% in Q1 2026, contradicting IPO disclosures.

SK Hynix completed a landmark $26.5 billion US IPO on July 10, 2026, listing 177.9 million American depositary shares at $149 each on Nasdaq under ticker SKHY. The South Korean memory-chip manufacturer, a major AI infrastructure supplier, became the largest US IPO by a foreign company. The company benefits from strong demand for high-bandwidth memory (HBM) products used in AI processors, but faces risks from cyclical memory markets, competition from Samsung and Micron, and geopolitical exposure.

The proposed offering comprises a fresh issue of shares worth as much as ₹1,785 crore and an offer for sale of up to ₹250 crore by founders, according to the draft prospectus.

Anthropic, the developer of Claude large language models, is approaching a trillion-dollar valuation and confidentially filed for an IPO on June 1. Three early investors—Alphabet, Amazon, and Zoom Communications—are positioned to realize substantial windfall profits from their investments made in 2023 and beyond. Alphabet holds a 14% stake worth approximately $135.1 billion, Amazon's $8 billion investment has grown more than ninefold to $74.2 billion, and Zoom's initial investment has ballooned to $1.3 billion.

Black Rock Coffee Bar faces a securities class action lawsuit alleging its IPO documents failed to disclose that new store openings were cannibalizing existing store revenues through a 'sales transfer' phenomenon. The company's stock has declined over 61% from its $20 IPO price to $7.72, with Q1 2026 earnings revealing a 160-basis point headwind to same-store sales growth from this undisclosed issue.

SpaceX completed the largest IPO in history, with shares opening at $150 (priced at $135) and reaching a peak of $226 before pulling back to $162. The article draws parallels to Snowflake's 2020 IPO, which also experienced dramatic first-day gains but delivered flat returns after nearly six years. The author warns that SpaceX's hype-driven momentum could lead to similar disappointment for early investors if valuations revert to more reasonable levels.